key: cord-0712924-6og4e47r
authors: Gale, Paul
title: Using thermodynamic equilibrium models to predict the effect of antiviral agents on infectivity: Theoretical application to SARS-CoV-2 and other viruses.
date: 2021-12-04
journal: Microb Risk Anal
DOI: 10.1016/j.mran.2021.100198
sha: 3469649e93d56d07e35f4cf6b1b5a4621208ca5d
doc_id: 712924
cord_uid: 6og4e47r

Thermodynamic equilibrium models predict the infectivity of novel and emerging viruses using molecular data including the binding affinity of the virus to the host cell (as represented by the association constant K(a_virus_T)) and the probability, p(virogenesis), of the virus replicating after entry to the cell. Here those models are adapted based on the principles of ligand binding to macromolecules to assess the effect on virus infectivity of inhibitor molecules which target specific proteins of the virus. Three types of inhibitor are considered using the thermodynamic equilibrium model for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection of the human lung with parameters for the strength and nature of the interaction between the target virus protein and the inhibitor molecule. The first is competitive inhibition of the SARS-CoV-2 spike glycoprotein (SGP) trimer binding to its human angiotensin converting enzyme 2 (ACE2) receptor by unfractionated heparin (UFH). Using a novel approach presented here, a value of K(a_virus_T) = 3.53 × 10(17) M(−1) is calculated for SARS-CoV-2 from the IC(50) for inhibition by UFH of SARS-CoV-2 plaque formation in cell culture together with the dissociation constant K(VI) of 0.73 × 10(−10) M reported for heparin binding to SARS-CoV-2 SGP trimer. Such a high K(a_virus_T) limits the effectiveness of a competitive inhibitors such as UFH. The second is the attachment of a nanoparticle such as a zinc oxide tetrapod (ZnOT) to the virus shell as for herpes simplex virus (HSV). The increase in molecular weight through ZnOT attachment is predicted to decrease K(a_virus_T) by orders of magnitude by making the entropy change (ΔS(a_immob)) on immobilisation of the ZnOT:virus complex on cell binding more negative than for the virus alone. According to the model, ZnOT acts synergistically with UFH at the IC(50) of 33 μg/cm(3) which together decrease viral infectivity by 61,000-fold compared to the two-fold and three-fold decreases predicted for UFH alone at the IC(50) and for ZnOT alone respectively. According to the model here, UFH alone at its peak deliverable dose to the lung of 1,000 μg/cm(3) only decreases infectivity by 31-fold. Practicable approaches to target and decrease ΔS(a_immob) for respiratory viruses should therefore be considered. The combination of decreasing ΔS(a_immob) together with blocking the interaction of virus surface protein with its host cell receptor may achieve synergistic effects for faecal-oral viruses and HSV. The third is reversible noncompetitive inhibition of the viral main protease (M(pro)) for which the decrease in p(virogenesis) is assumed to be proportional to the decrease in enzyme activity as predicted by enzyme kinetic equations for a given concentration of inhibitor which binds to M(pro) with dissociation constant K(i). Virologists reporting viral inhibition studies are urged to report the concentration of cells in the cell culture experiment as this is a key parameter in estimating K(a_virus_T) here.

In addition to the development of vaccines against coronavirus disease 2019 , both the repurposing of existing clinical drugs such as unfractionated heparin (UFH) (Tree et al. 2020 ) and the structure-based design of novel drugs which target severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) specific proteins are being pursued. As an example of the latter, have focused on inhibitors of the main protease (M pro , also called 3CL pro ) of SARS-CoV-2. Much research effort is directed at drugs such as UFH (Tree et al. 2020 ) and the monoclonal antibody MAb362 (Ejemel et al. 2020 ) which inhibit the entry of virus to the host cell by binding to the receptor binding domain (RBD) on the head of the SARS-CoV-2 spike glycoprotein (SGP) trimer and so blocking its interaction with the host cell receptor (Cr) angiotensin converting enzyme 2 (ACE2). This is shown in Figure 1 . Most inhibitor studies report the total inhibitor concentration (IC 50 ,) that reduces infectivity by 50%; for example the amount of UFH or MAb362 in g/cm 3 required to reduce the number of SARS-CoV-2 viral plaques on monolayers of Vero cells by 50% compared with the virus only control. The strength of an inhibitor can be also quantified by the thermodynamic dissociation constant which defines the strength of its binding either to the individual virus surface protein e.g. the SGP trimer (K di ), or to the whole virus (K VI ), or to the target viral enzyme (K i ) in the case of M pro . It is demonstrated here that these inhibitor dissociation constants enable the theoretical modelling of the effects of inhibitors on viral infectivity in human hosts through thermodynamic equilibrium models.

Previously a prototype thermodynamic equilibrium model has been developed for a dose-response for a respiratory virus such as SARS-CoV-2 (Gale 2020a) . That model is based on a number of biophysical and molecular parameters that can be translated into probabilities for the purpose of assessing the overall probability of infection by a single virion. The component probabilities are summarised in Table 1 . The effects of inhibitors on two of the probabilities, namely the fraction, F B , of virus particles in the challenge dose which are bound to host cells and the probability, p virogenesis , of the virus replicating after entry to the cell, are considered here. Central to F B is the magnitude of the thermodynamic association constant K a_virus_T which defines the binding affinity of the virus to the host cell. The magnitude of K a_virus_T is not only dependent on the strength and number of SGP trimer/ACE2 interactions during virus binding but also on the entropy decrease (ΔS a_immob ) on immobilisation of the whole virus on the host cell surface Gale 2020b ). An important conclusion of the work here is that the very strong binding of SARS-CoV-2 to human cells through the ACE2 receptor as represented by the high K a_virus_T value reduces the effectiveness of heparin as an inhibitor. However, making ΔS a_immob more negative by increasing the molecular weight of the virus on attaching to a large inert particle such as a zinc oxide tetrapod (ZnOT) nanoparticle increases the potency of heparin in reducing F B with the two inhibitors acting synergistically.

The magnitude of K a_virus_T is known for relatively few viruses (Popovic and Minceva 2021) . This may reflect the difficulty in measuring K a_virus_T experimentally and to the author's knowledge there are no data on K a_virus_T for SARS-CoV or SARS-CoV-2. An outcome of the thermodynamic equilibrium analysis developed here is that K a_virus_T can be calculated directly from K VI and IC 50 data which have been reported in drug inhibition studies. This is demonstrated for SARS-CoV-2 using data for UFH inhibition of SARS-CoV-2 plaque formation in cell culture from Tree et al. (2020) . For comparison K a_virus_T is also estimated for adeno-associated virus (AAV) using heparan sulphate (HS) inhibition data from Negishi et al. (2004) . K VI values for heparin binding to the virus are calculated here from dissociation constants, K di , measured experimentally for heparin binding to the SGP trimer of SARS-CoV-2 (Kim et al. 2020) and the capsid protein of AAV-2 (Negishi et al. 2004) . The K a_virus_T is then used to model the effects of inhibitors on the infectivity of SARS-CoV-2 through reducing F B .

A competitive inhibitor such as heparin which binds reversibly to SARS-CoV-2 with a given K VI value will compete with the ACE2 receptors on the host cell for the RBD on the SGP trimer and hence decrease the fraction, F B , of virus bound to host cells (Figure 1 ) depending on the relative values of K VI and K a_virus_T . It is important to note that K a_virus_T is a constant and its value will not be affected by the presence of inhibitor. Liu et al. (2020) consider it is intuitive that at least some cell surface receptors are needed to provide a minimum attraction to counteract the loss in translational entropy (S trans ) of the virus on its binding to the host cell. The entropy loss on the immobilisation of the virus to the host cell has previously been formally identified and defined as ΔS a_immob (Gale 2019 ) and has been suggested as an alternative target for antiviral therapy (Gale 2020b) based for example on the inhibition of herpes simplex virus (HSV) by binding of ZnOT nanoparticles to the virus (Antoine et al. 2012) . Specifically the objective is to make ΔS a_immob more negative in magnitude. Only one ZnOT has to bind to a virus ( Figure 1h ) to greatly increase the mass of the virus and its rotational moments of inertia and hence make ΔS a_immob more negative in magnitude. It is not known whether other viruses including SARS-CoV-2 also bind to ZnOT. Specifically Antoine et al. (2012) show negative charges on the ZnOT surface attracting positively charged groups on the HSV surface and so binding the virus through non-specific electrostatic interactions. The same sites that bind heparin on the SARS-CoV-2 SGP are also positively charged (Mycroft-West et al. 2020 ) and therefore a SARS-CoV-2 virion could theoretically bind to ZnOT through multiple electrostatic interactions with the SGPs exactly as proposed for HSV which also binds to negatively charged HS on the cell surface through the same mechanism (Antoine et al. 2012) . Similarly AAV-2 also has positive charges on its surface to bind heparin (Zhang et al. 2013 ) and thus could also bind ZnOT in theory. There is no reason spatially why an enveloped virion attached to a ZnOT particle could not also bind to cellular receptors in effect acting as a linker attaching the ZnOT particle to the cell (Figure 1i ). Indeed many biochemical assay methods are based on specific linking of biomolecules. Membrane fusion could then proceed resulting in entry of the viral core leaving the ZnOT on the outside. Here the Sackur-Tetrode equation (Gasser and Richards 1974) is used to estimate ΔS a_immob for the virus bound to a ZnOT nanoparticle using the molecular weight calculated for the ZnOT nanoparticle/virus complex ( Figure 1h ) and so estimate the effect of ZnOT attachment to the virus on K a_virus_T . Since ZnOT targets ΔS a_immob and heparin blocks SGP/ACE2 binding they inhibit virus entry in different ways and could therefore in theory act synergistically (Figure 1j ). Although there would clearly be problems in inhaling thousands of ~1 m diameter ZnOT nanoparticles into the lungs as a therapy against SARS-CoV-2 for example, the synergistic effect of both is considered here for the purpose of developing the model for other viruses such as HSV and even faecal-oral viruses which infect humans through other routes of entry. Other approaches than attaching the virus to a massive nanoparticle need to be explored to make ΔS a_immob more negative in magnitude, as these could be applied to respiratory viruses.

The viral main protease, M pro , is an attractive drug target for human coronaviruses because it is a viral enzyme and with no known human proteases with a similar cleavage specificity, inhibitors are unlikely to be toxic . After entry to the cell the SARS-CoV-2 RNA (Figure 1k ) is translated giving a large polyprotein which is cleaved at 11 sites by M pro . Inhibiting the activity of this enzyme would block viral replication greatly diminishing the value of p virogenesis in Table 1 . The objective of the work here is to use published K i values for M pro inhibition to model the effect of the concentration of inhibitor on p virogenesis and hence predict the decrease in infectivity of the virus.

The abbreviations are listed in Table 2 .

On inhalation of aerosols containing respiratory viruses such as SARS-CoV-2, a proportion enter the mucus in the respiratory tract and lung lining fluid. The probability, p host , of initial infection of the host (Gale 2020a) is given by

where V mucus is the total virus dose entering lung mucus during initial exposure of the host and p 1 is the probability of initial infection of the host by a single virion in the mucus.

On the basis of the dose-response for infection of a respiratory virus (Gale 2020a), p 1 may be broken down into a series of probabilities according to

where F v is the fraction of virus in lung mucus not bound to mucin, i.e. free to bind to epithelial cells, p pfu is the probability that a given virion is itself capable of initiating infection in a cell, F B is the fraction of virus bound to epithelial cells, p entry is the probability that a virion bound to the cell surface enters that cell, p virogenesis is the probability that the virus replicates within the cell after entry and progeny virions are assembled, and p budding is the probability that the progeny virions exit the infected cell. With the exception of p pfu each of these probability steps could be targeted by drug therapies as shown in Table 1 .

In the absence of data on whether SARS-CoV-2 binds to human mucin (Chatterjee et al 2020) , F v is set to 1.

The value of p pfu is set to 0.0001 based on there being ~10 4 RNA copies per pfu for SARS-CoV-2 replicating in human airway tissues over 5 days post infection (Plante et al. 2020) . Of 39,778 lung cells studied by Lukassen et al. (2020) , 206 expressed ACE2 and of those only 104 expressed both ACE2 and transmembrane protease/serine protease (TMPRSS2) and/or furin. TMPRSS2 is required to cleave the SGP resulting in membrane fusion and cell entry of the virion. Thus given SARS-CoV-2 has bound to a cell there is a 0.5 (104/206) probability that it will be able to enter and p entry is set to 0.5. The values of p virogenesis and p budding are set to 1 (Gale 2020a) . Modelling F B is now described.

Each SGP trimer binds reversibly to an inhibitor (I) molecule such as UFH with a dissociation constant, K di , which is determined experimentally (Kim et al. 2020) . The lower the magnitude of K di the stronger the binding. Many viruses contain multiple (n) copies of the surface proteins that bind to the cellular receptors and hence also to competitive inhibitors. For example one AAV-2 capsid has n = 20 HS binding sites (Negishi et al. 2004 ) and the SARS-CoV and SARS-CoV-2 virions each have n = 74 SGP trimers (Popovic and Minceva 2020) . According to Price and Dwek (1979) For a virion with an inhibitor molecule bound to each and every one of the n SGP trimers, the K VI is related to the dissociation constant, K di , measured in a laboratory for a single SGP trimer/I interaction by

This is because statistically each I molecule can dissociate from a V free .I n complex in n ways but the free I molecule can only associate with V free .I (n-1) in one way (Price and Dwek 1979 For the purpose of simplifying the model here in Figure 2 , it is assumed that the V free .I (n-1) entity makes the first SGP/ACE2 interaction with its one free SGP trimer in the cases of SARS-CoV and SARS-CoV-2.

However, the virion is spherical and the 74 SGP trimers all point in different directions being normal to the sphere surface. There are therefore spatial considerations to be considered in that only the one SGP trimer of the n = 74 trimers on the virus surface that is immediately opposite to an ACE2 receptor molecule on the host cell surface can result in binding. Therefore there is only one in 74 UFH dissociations that can result in a binding and it is proposed that the effective K VI is reduced by a factor of n such that ≡

The scheme for the interaction of the virus (V) with a host cell (C) and a specific inhibitor (I) is set out in For low challenge doses such that the number of viruses is much fewer than the number of target cells, C free may be approximated by C total which is calculated in the case of SARS-CoV-2 as the fraction of lung cells expressing ACE2 on their surface (Gale 2020a) . Of 39,778 lung cells studied by Lukassen et al. (2020) , the number expressing ACE2 was 206 accounting for 0.52% of the 320 x 10 9 cells in the human lung (Crapo et al 1982) . The value for [C free ] is 8.0 x 10 -14 M on the basis of 1.2 x 10 9 susceptible lung cells expressing ACE2 in 0.025 dm 3 of lung lining fluid (Gale 2020a).

While inhibitor binding to SGP trimers must be tight to be effective with small K di values, it must also be reversible for the model in 

When the fraction of viruses bound to host cells in the presence of inhibitor, F Bi , is equal to half that in the absence of inhibitor, F B0 , then the probability, p host , of infection will be halved because p 1 in Equation 1 

in agreement with the classic expression for competitive inhibition of enzymes (Cer et al 2009) . The value of K a_virus_T is then derived from Equation 9 as

_

and is calculated here using published data for dissociation constants and IC 50 s for UFH binding to SARS-CoV-2 and for HS binding to AAV-2 (Table 3) . Equation 10 gives a negative K a_virus_T when IC 50 < K VI which is meaningless. It should be stressed that K VI are not the same as the IC 50 and in all systems with host cells present IC 50 will be greater than K VI . pH and other factors including temperature (Gale 2020b) affect the strength of virus binding and it is assumed here for the purpose of demonstration that conditions are similar in the cell culture experiments, the human lung and in the SGP/UFH binding experiments.

As presented previously (Gale 2019 (Gale , 2020b , the magnitude of K a_virus_T can also be estimated from thermodynamic parameters as

where K d_receptor_T is the dissociation constant for the SARS-CoV-2 SGP trimer from its ACE2 at temperature T, N v is the number of SGP/ACE2 interactions on virus/host cell binding and ΔS a_immob is the change in entropy on immobilization of whole virus on binding to the cell surface. Increasing ΔS a_immob by the amount ΔΔS a_immob (i.e. the difference between the values of ΔS a_immob(virus) for the SARS-CoV-2 virion and ΔS a_immob(virus:ZnOT) for the SARS-CoV-2 virion attached to ZnOT) therefore increases K a_virus_T by a factor of

_ _ ( )

The ΔS a_immob term in Equation 11 is itself comprised of several entropy terms

including the changes in translational and rotational entropy of the whole virus (ΔS trans and ΔS rot respectively) and an entropic pressure (ΔS mem ) associated with bringing two membranes close together, as for example, when the virus envelope approaches the host cell membrane (Sharma, 2013) .

The ΔS trans and ΔS rot terms are now considered.

The absolute translational entropy per mol of the free virus, S trans (free virus), is estimated here by the Sackur-

(

where R is the ideal gas constant, h is the Planck constant, k B is the Boltzmann constant, p is the atmospheric pressure (101,325 Nm -2 ), L is the Avogadro number and T is the temperature (298 K). The change in translational entropy on virus binding, ΔS trans , is calculated as:-

where S trans (bound virus) is the absolute translational entropy of the virus bound to the host cell. The virus has to adopt a certain orientation ) at the point of entry to the cell as the virus membrane fuses with the cell membrane in the case of enveloped viruses such as SARS-CoV-2. Some viruses involve chlathrin-coated pits which would give considerable immobilisation of the virus both in terms of lateral diffusion and rotation. For example African swine fever virus enters macrophages through chlrathinmediated endocytosis (Andres 2017) . It is tempting to assume that S trans (bound virus) = 0 J/mol/K because the bound virus is immobilised and thus cannot move in the x, y or z directions. However, even in a protein crystal the individual atoms can vibrate in the principal directions about their mean positions with r.m.s.

amplitudes of 0.03 to 0.05 nm and the whole proteins themselves can move within a crystal by distances of 0.02 to 0.025 nm (Finkelstein and Janin 1989) . Such motions no doubt occur in the atoms of a bound virus, and in the case of enveloped viruses the phospholipids in the envelope will still be able to diffuse within the bilayer. Furthermore, depending on the mobility of the Cr molecule(s) to which the virus is bound, the virus-Cr complex may be able to undergo lateral diffusion within the two dimensional lipid bilayer. Kukura et al. The negative value of ΔS trans reflects the increase in order as the virus is immobilised.

On binding of the virus to the cell surface rotation about two of the three principal axes will be prevented, although some rotation through the Cr molecule(s) about the normal axis to the membrane could occur depending on the rotational diffusion constant of the Cr molecule(s) within the phospholipid bilayer.

Finkelstein and Janin (1989) estimated ΔS rot for BPTI to be slightly more negative than that of the ΔS trans of -96.2 J/mol/K at -125 to -100 J/mol/K. Estimating the magnitude of the ΔS rot term involves calculation of the moments of inertia around the three principal axes using the atomic coordinates from the crystal structure as for BPTI (Finkelstein and Janin 1989) . This is not possible here for viruses, and for the demonstration purpose of this paper it is assumed that ΔS rot ~ ΔS trans as for BPTI and therefore that

where S trans (free virus) is given in Equation 14.

The M r of the SARS-CoV-2 virion is 2.20 x 10 8 Da as calculated from its molecular compositions (Popovic and Minceva 2020) . The ZnOT nanoparticles used by Antoine et al. (2012) for HSV treatment were large with arm diameters in the range of 200 nm to 1 m and arm lengths in the range of 5 m to 30 m. Smaller particles may have a broader application because they can be applied at higher particle densities and 

The strength of binding of an inhibitor to an enzyme is defined by the thermodynamic dissociation constant (Gale 2020a) it was assumed that p virogenesis equals 1, that is once the viral core has entered the cell then replication and capsid assembly is highly efficient. Thus p virogenesis in the presence of I is given by:-

= since when [I] = 0 M in Equation 18 then p virogenesis = 1.

Values of K a_virus_T are estimated in Table 3 for SARS-CoV-2 and AAV-2 using data for inhibition of infection by UFH (Tree et al. 2020) and HS (Negishi et al. 2004 ) respectively in Equation 10. 

The predicted effect of 2.1 M UFH on the virus dose response according to Equation 1 is shown in Figure   3b with (Table 4 ).

The magnitudes of ΔS a_immob for the SARS-CoV-2 virion and for the SARS-CoV-2 virion bound to a ZnOT nanoparticle as approximated from their M r s using the Sackur-Tetrode equation (Equation 14) are -348.3 J/mol/K and -439.9 J/mol/K respectively such that ΔΔS a_immob = 91.6 J/mol/K. Thus attaching a ZnOT nanoparticle to a SARS-CoV-2 virion decreases K a_virus_T by 61,000-fold (Equation 12) from 3.53 x 10 17 M -1 (Table 3) for free SARS-CoV-2 to 5.76 x 10 12 M -1 . The dose-response curves with F B in Equation 2

calculated using these K a_virus_T values in Equation 8 are plotted in Figure 4 . Complexing the virion with ZnOT decreases p 1 by three-fold (Table 4) 

UFH blocks SGP/ACE2 binding. Addition of UFH at a concentration of 2.1 M (equal to the IC 50 ) to free virus (Figure 4 solid line) decreases the infectivity as represented by p 1 by two-fold as expected for the IC 50 (Table 4) Figure 4 , the predicted effect of attaching a large ZnOT nanoparticle to the SARS-CoV-2 virion is shown together with the synergistic effect of adding a competitive inhibitor such as UFH that blocks the RBD of the SARS-CoV-2 SGP from binding to ACE2 on the host cell surface. The predicted effect on the dose-response of an inhibitor that blocks virogenesis of SARS-CoV-2 is demonstrated in Figure 5 .

The value of K a_virus_T is of key importance not only in determining the strength of cell binding (Popovic and Minceva 2021) but also in influencing the effect of a competitive inhibitor on the fraction, F B , of virus bound to host cells as shown in Figure 3a . It is difficult to measure experimentally and there do not appear to be data for SARS-CoV-2 as yet (Popovic and Minceva 2021) . However it can be calculated in Equation 10 from the K VI and the IC 50 values which are easier to measure and have been quantified in SARS-CoV-2 and AAV-2 inhibition studies (Table 3) . A value for K a_virus_T of 3.53 x 10 17 M -1 is estimated here for SARS-CoV-2 using heparin inhibition data and represents high affinity binding. This is in agreement with theoretical estimates made previously using the K d_receptor_T of 1.47 x 10 -8 M reported for SARS-CoV-2 SGP trimer binding to a single ACE2 protein (Wrapp et al. 2020) One apparent anomaly in the model is that K VI is based on just one inhibitor molecule dissociating from the V free .I n entity (Equation 5) allowing just one SGP trimer to bind to an ACE2 receptor while the value of K a_virus_T predicted in Table 3 is so high as to require N v to be greater than one in Equation 11. This can be explained as follows. Once the first SGP trimer/ACE2 receptor interaction has been made, further interactions will be made by neighbouring ACE2 receptors on the host cell competitively displacing heparin molecules from adjacent SGP trimers on the virus with very similar K di values to K VI because each SGP trimer/heparin interaction is assumed to be identical and independent (Price and Dwek 1979 Thus each MAb362 sIgA could contact up to four SGP trimers on a SARS-CoV-2 virion such that K VI is much lower than the K di reported by Ejemel et al. (2020) . For this reason K a_virus_T is not calculated with MAb362 inhibition data here.

One source of uncertainty in K a_virus_T estimated for SARS-CoV-2 and AAV-2 in Table 3 using Equation 10 from inhibition studies is the molar concentration of Vero E6 cells in the plaque assays used. Here it is assumed that the [C total ] value in the plaque inhibition assay and used as an approximation for [C free ] in Equation 10 to calculate K a_virus_T is the same as that estimated for cells expressing ACE2 in the human lung epithelium at 8 x 10 -14 M (Gale 2020a) . This also ensures the measured IC 50 also achieves a 50% reduction in the probability of infection in the dose-response for infectivity in Figure 4 for the purpose of demonstration of the models here. It is likely that the concentration of cells in the plaque inhibition assays in Tree et al.

(2020) is lower such that the predicted K a_virus_T values using Equation 10 would be higher than those in Table 3 .

It is concluded from Figure 3a that the high binding affinity of the SARS-CoV-2 virion to its host cell based on its high K a_virus_T diminishes the effectiveness at decreasing F B by inhibitors that competitively block the RBD of the SGP binding to ACE2. Specifically high values of K a_virus_T at >10 15 M -1 and >10 17 M -1 undermine inhibition by competitive inhibitors with K VI values of ~10 -8 and ~10 -10 M, respectively with at least 20% of the virus still bound to host cells (Figure 3a ). From Equation 9 the higher the K a_virus_T then the higher the inhibitor concentration required to achieve a 50% inhibition of the virus as represented by the IC 50 . Thus, heparin may be more effective against AAV-2 due to the lower K a_virus_T for AAV-2 than against SARS-CoV-2 even though heparin binds more tightly to SARS-CoV-2 SGP than to AAV-2 according to the K VI values (Table 3 ). The peak amount of UFH that can be delivered to the lung is 400 -2,600 g/ cm 3 (Tree et al. 2020 ). Even at a concentration of 1,000 g/cm 3 (62.5 M), UFH only decreases the infectivity by 31fold according to the model here ( Figure 4) . From Figure 3a an approach is needed to reduce K a_virus_T for SARS-CoV-2 to <10 15 M -1 at which UFH at a concentration of just 2.1 M (assuming K VI of 0.73 x 10 -10 M for SARS-CoV-2 SGP trimer (Kim et al. 2020)) would reduce F B to 0.003 (dotted line in Figure 3a ) in effect inhibiting infectivity by 99.7% and shifting the dose-response curve for SARS-CoV-2 by almost three orders of magnitude (dotted line in Figure 3b ).

Decreasing the magnitude of K a_virus_T for SARS-CoV-2 to <10 15 M -1 could be achieved by a second inhibitor which specifically binds to the virus and increases its overall M r so making ΔS a_immob more negative in magnitude. According to the approximation here based on the Sackur-Tetrode equation the attachment of a

ZnOT nanoparticle to a SARS-CoV-2 virion decreases the K a_virus_T to 5.76 x 10 12 M -1 . This is in the range where competitive inhibition of the SGP/ACE2 binding by UFH at relatively low concentration (2.1 M) has a significant effect on the fraction, F B , of SARS-CoV-2 bound to host cells (dotted line in Figure 3a ) and even has a considerable effect on F B for a virus which is more weakly inhibited as for HS binding to AAV-6 capsid protein (dashed line in Figure 3a ). In summary, while UFH alone at a concentration of 2.1 M reduces the risk two-fold for SARS-CoV-2 as expected at the IC 50 concentration, UFH still at 2.1 M concentration but combined with ZnOT gives a 61,000-fold decrease in infectivity (Figure 4 ).

The importance of the loss of translational entropy in ΔS a_immob on virus binding to the host cell is acknowledged by Liu et al. (2020) . While the M r of the virion is known with great accuracy for SARS-CoV-2 (Popovic and Minceva 2020) , the values of ΔS a_immob calculated here using the Sackur-Tetrode equation (Equation 14) for such large particles are at best approximations. However they are sufficient for the purpose of demonstrating the potential for developing drugs to target ΔS a_immob .

While the magnitude of K a_virus_T is very sensitive to changes in ΔS a_immob according to Equation 12, ΔS a_immob is not very sensitive to M r and to significantly decrease ΔS a_immob for a virus requires attachment of a much larger particle such as ZnOT. This is because of the logarithmic nature of the effect of M r on the magnitude of S trans according to the Sackur Tetrode equation (Equation 14 ). Thus, even though the M r of the ZnOT nanoparticle is 1,540-fold greater than that of the SARS-CoV-2 virion it only decreases ΔS a_immob by 26% from -348.3 J/mol/K to -439.8 J/mol/K. The effect on decreasing K a_virus_T of attaching a ZnOT will be greater for a smaller virus compared to a larger virus such as SARs-CoV-2. For example ΔS a_immob is approximated by the Sackur-Tetrode equation at -307.4 J/mol/K for the smaller foot-and-mouth disease virus virion on the basis of its Mr = 8.3 x 10 6 (van de Woude et al. 1972 ) and would be decreased by 43% by attachment to a ZnOT.

The logarithmic relationship of ΔS a_immob and M r in the Sackur-Tetrode equation demonstrates a practical limitation in attaching large particles to virions as a means disrupting the thermodynamics of virus binding to host cells although physical entrapment itself may be important as shown for HSV binding within the crevice of a ZnOT nanoparticle (Antoine et al. 2012) . Furthermore the inhalation of ZnOT nanoparticles will not be practicable to a respiratory virus such as SARS-CoV-2. Other approaches to targeting ΔS a_immob should be considered including the entropy decrease (ΔS mem ) when the virus and host membranes approach on binding (Sharma 2013) .

The K a_virus_T needs to be <10 12 M -1 in the absence of UFH to have a major impact on F B (Figure 3a In practice the effect of ZnOT on infectivity may be greater than just three-fold because its attachment to the virus surface would also prevent some of the n = 74 SGP trimers on the SARS-CoV-2 ( Figure 1h ) from interacting with ACE2 and the tetrapod structure may entrap virions so they are not physically able to contact the cell surface. The purpose of the model here is merely to demonstrate the effect of an inhibitor that targets ΔS a_immob . The larger ZnOT particles used by Antoine et al. (2012) for HSV have much larger M r and hence would decrease ΔS a_immob even more in magnitude.

The effect of inhibitors of the SARS-CoV main protease (M pro ) is taken directly from enzyme kinetics (Basha et al. 2004 ) and applied to p virogenesis as the decrease in reaction rate in the presence of inhibitor, v Inhib, relative to the rate in the absence of inhibitor, v 0 in Equation 19 . This allows the decreases in predicted infectivity to be related to published K i values and inhibitor concentrations as shown in Figure 5 .

The IC 50 is always greater than the K VI in Equation 10 because the Cr receptors on the host cells compete against the inhibitor for the binding sites on the surface proteins on the virus. The IC 50 value is often reported in inhibition studies instead of the K VI . The K VI has the advantage that it is a thermodynamic dissociation constant that can be used directly as a parameter in the models developed here which can be adapted to model different hosts for example. In contrast the IC 50 value is less flexible because it depends on the system in which it was measured (Cer et al. 2009 ). Specifically according to Equation 9 the IC 50 depends both on the host cell concentration ([C free ]) and on the strength of virus binding to those host cells as represented by K a_virus_T . Both these parameters in cell culture may be different from those in a live host such that the IC 50 is not necessarily representative of the concentration that will give a 50% decrease in the probability of infection of the host. Thus if the concentration of susceptible cells is higher in the human lung than in the experimental cell culture study, then the IC 50 measured in the laboratory may need to be revised upwards for effective therapy in the patient according to Equation 9. The beauty of reporting both the IC 50 and the K VI value is that K a_virus_T can be also calculated provided [C total ] is also reported in to order to approximate [C free ] in Equation 10.

The assumption in Equation 5 that free virus is either in the V free .I n or V free .I (n-1) form will not hold at low [I] according to Equation 4. However it is satisfactory for the demonstration of proof of principle here. The model should be developed further to include the complete range of V.I entities from V free , V free .I, V free .I 2 , ….., V free .I (n-2) , V free .I (n-1) , to V free .I n . This is complicated mathematically and indeed each of these entities will have its own K VI based on K di and the number of ways I can dissociate and associate as set out by Price and Dwek (1979) . Furthermore consideration needs to be taken of the spatial distribution of the I molecules on the virus. For example for SARS-CoV-2, a V free .I 70 entity has four SGP trimers free to bind to ACE2

receptors. If these four free SGP trimers are adjacent on the virus surface (which is statistically very unlikely) then they can each bind an ACE2 molecule on the initial contact with the host cell surface giving N v = 4 in Equation 11 such that K a_virus_T is very high. Statistically it is much more likely that the four free SGP trimers on V free .I 70 will be on opposite sides of the sphere so that initial binding of V free .I 70 is through During viral replication in the host cell, a substantial number of progeny virions do not contain RNA and are not infectious such that p virogenesis = 0. These "empty virus" could act as inhibitors by binding to ACE2

receptors on the host cell surface, although their SGP trimers would also mop up UFH and could even bind to mucins thus locally overcoming the host innate response (see Gale 2020a) . Further development of the thermodynamic model should consider these empty viruses. The model can be parameterised for other SARS-CoV-2 variants once IC 50 and K di are obtained experimentally.

The response considered here, namely initial infection of the host, happens before the innate immune response and the acquired immune response both of which are important for stopping progression of coronavirus infection in the host (Lim et al. 2016) . The objective of the inhibitor in this prototype model is to decrease p 1 and no attempt is made here to allow for the stage in the infection process at which the inhibitor is applied. The prototype model is therefore theoretical and could also be applied to modelling the effect of viral inhibitors on human lung cell culture lines where the response is production of at least one plaque. In the human host, once initial infection has taken place for example in the nasal epithelium of a person infected with SARS-CoV-2, infection progresses to the bronchioles and alveoli of the lung (Hou et al 2020) . There are not sufficient data and understanding to model the innate and acquired immune responses and these are therefore ignored in this prototype model, although removal by mucus is considered through F v . The aim of this paper is to produce a prototype model for the effect of inhibitors on the infectivity of the virus and focuses on the effect of inhibitors on p 1 in Equation 2 through F B (Equation 8) and p virogenesis (Equation 18 and Equation 19 ). Thus assuming the innate and acquired immune responses are constant and are not affected by the drugs, then their effect on the relative decrease in p 1 with the drug compared to without the drug cancels out, such that the model allows the changes in p 1 (and hence ID 50 ) with and without drugs to be modelled.

The reader should therefore focus on the changes in p 1 (and hence ID 50 ) on addition of drugs rather than their absolute values. The dose-response parameters (namely p 1 and ID 50 ) presented here are representative of initial infection in an immunologically naïve person in the absence or presence of the drug. Such a high K a_virus_T value for SARS-CoV-2 would hinder the effectiveness of competitive inhibitors such as heparin that block SGP binding to the ACE2 receptor on the host cell, i.e. those viruses which bind the host cell more strongly are more difficult to inhibit and require inhibitors with lower K VI values than viruses that bind more weakly. An alternative approach is to find a second inhibitor to decrease the magnitude of K a_virus_T prior to use of heparin.

In theory, K a_virus_T may be decreased by orders of magnitude by attachment of a ZnOT nanoparticle to the virus as used for inhibition of herpes simplex virus binding. This targets the entropy of immobilisation of the virus as opposed to the SGP/ACE2 interaction and renders the virus infectivity much more susceptible to inhibitors that block SGP/ACE2 binding. At the IC 50 concentration, heparin decreases infectivity by 50% as expected, but with the attachment of a ZnOT nanoparticle to the virion, its infectivity is decreased 61,000fold at the same heparin concentration, demonstrating the synergistic effect of these competitors. Increasing the heparin concentration to 1,000 g/ cm 3 only achieves a 31-fold reduction in infectivity according to the model here.

Since inhaling ZnOT nanoparticles is not practicable as a therapy for respiratory viruses, other approaches to targeting the entropy of immobilisation of the virus should be considered. These include the entropy decrease when the virus and host membranes approach.

The combination of targeting the entropy of immobilisation together with blocking the interaction of virus surface protein with its host cell receptor may achieve synergistic effects for non-respiratory viruses for example herpes simplex virus and faecal-oral viruses. The limited effect on SARS-CoV-2 predicted for ZnOT alone reflects the high concentration of susceptible cells in the lung. The application of ZnOT alone will be more effective at lower host cell concentrations such as in the intestine. 

Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection

African swine fever virus gets undressed: New insights on the entry pathway

Identification of novel inhibitors of the SARS coronavirus main protease 3CL pro

IC 50 -to-K i : a web-based tool for converting IC 50 to K i values for inhibitors of enzyme activity and ligand binding

Defensive properties of mucin glycoproteins during respiratory infections -relevance for SARS-CoV-2

Cell number and cell characteristics of the normal human lung. The American review of respiratory disease

A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction

The price of lost freedom: entropy of bimolecular complex formation

Thermodynamic equilibrium dose-response models for MERS-CoV infection reveal a potential protective role of human lung mucus but not for SARS CoV-2.Microbial Risk Analysis

How virus size and attachment parameters affect the temperature sensitivity of virus binding to host cells: Predictions of a thermodynamic model for arboviruses and HIV. Microbial Risk Analysis 15

Towards a thermodynamic mechanistic model for the effect of temperature on arthropod vector competence for transmission of arboviruses

Using thermodynamic parameters to calibrate a mechanistic dose-response for infection of a host by a virus. Microbial Risk Analysis

Determination of partition functions

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract

High-speed nanoscopic tracking of the position and orientation of a single virus

The structures of secretory and dimeric immunoglobulin A. eLife, 9

Human coronaviruses: A review of virus-host interactions

Combinatorial entropy behaviour leads to range selective binding in ligandreceptor interactions

SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells

Heparin inhibits cellular invasion by SARS-CoV-2: Structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin

Thermodynamic insight into viral infections 2: empirical formulas, molecular compositions and thermodynamic properties of SARS

Coinfection and interference phenomena are the results of multiple thermodynamic competitive interactions

Principles and problems in physical chemistry for biochemists

Entropic force between membranes reexamined

Unfractionated heparin inhibits live wild-type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations

Chemical and physical properties of foot-andmouth disease virus: A comparison with maus elberfeld virus

Coronaviridae and SARS-associated coronavirus strain HSR1. Emerging infectious diseases

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors

Dose-response relation deduced for coronaviruses from COVID-19, SARS and MERS Meta-analysis results and its application for infection risk assessment of aerosol transmission

None declared.

The views expressed in this paper are those of the author and not necessarily those of any organisations.